BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 22123357)

  • 1. Fractional transepidermal delivery: a histological analysis.
    Beltraminelli H; Dietrich N; Hunziker T
    Dermatology; 2011; 223(4):321-4. PubMed ID: 22123357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of histological findings of single session Er:YAG skin fractional resurfacing with various passes and energies and the possible clinical implications.
    Trelles MA; Vélez M; Mordon S
    Lasers Surg Med; 2008 Mar; 40(3):171-7. PubMed ID: 18366083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue-engineered skin in the treatment of vitiligo lesions.
    Arenberger P; Broz L; Veselý P; Havlícková B; Matousková E
    Folia Biol (Praha); 2000; 46(4):157-60. PubMed ID: 10954161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ex vivo histological characterization of a novel ablative fractional resurfacing device.
    Hantash BM; Bedi VP; Chan KF; Zachary CB
    Lasers Surg Med; 2007 Feb; 39(2):87-95. PubMed ID: 17115384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term follow-up study of segmental and focal vitiligo treated by autologous, noncultured melanocyte-keratinocyte cell transplantation.
    Mulekar SV
    Arch Dermatol; 2004 Oct; 140(10):1211-5. PubMed ID: 15492183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination treatment by 10 600 nm ablative fractional carbon dioxide laser and narrowband ultraviolet B in refractory nonsegmental vitiligo: a prospective, randomized half-body comparative study.
    Shin J; Lee JS; Hann SK; Oh SH
    Br J Dermatol; 2012 Mar; 166(3):658-61. PubMed ID: 22050270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ratio of size of recipient and donor areas in treatment of vitiligo by autologous cultured melanocyte transplantation.
    Hong WS; Hu DN; Qian GP; McCormick SA; Xu AE
    Br J Dermatol; 2011 Sep; 165(3):520-5. PubMed ID: 21564070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo histological evaluation of a novel ablative fractional resurfacing device.
    Hantash BM; Bedi VP; Kapadia B; Rahman Z; Jiang K; Tanner H; Chan KF; Zachary CB
    Lasers Surg Med; 2007 Feb; 39(2):96-107. PubMed ID: 17311274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pilot clinical study of a novel minimally invasive bipolar microneedle radiofrequency device.
    Hantash BM; Renton B; Berkowitz RL; Stridde BC; Newman J
    Lasers Surg Med; 2009 Feb; 41(2):87-95. PubMed ID: 19226570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of vitiligo by transplantation of cultured pure melanocyte suspension: analysis of 120 cases.
    Chen YF; Yang PY; Hu DN; Kuo FS; Hung CS; Hung CM
    J Am Acad Dermatol; 2004 Jul; 51(1):68-74. PubMed ID: 15243526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fractional versus full ablative CO
    Jamal-Edine AM; El-Barbary RA; Moftah NH
    J Cosmet Dermatol; 2022 Apr; 21(4):1506-1513. PubMed ID: 34213808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autologous melanocyte transfer via epidermal grafts for lip vitiligo.
    Gupta S; Goel A; Kanwar AJ; Kumar B
    Int J Dermatol; 2006 Jun; 45(6):747-50. PubMed ID: 16796641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repigmentation in vitiligo patients. Melanocyte transfer via ultra-thin grafts.
    Kahn AM; Cohen MJ
    Dermatol Surg; 1998 Mar; 24(3):365-7. PubMed ID: 9537012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective comparison of recipient-site preparation with fractional carbon dioxide laser vs. dermabrasion and recipient-site dressing composition in melanocyte-keratinocyte transplantation procedure in vitiligo: a preliminary study.
    Silpa-Archa N; Griffith JL; Williams MS; Lim HW; Hamzavi IH
    Br J Dermatol; 2016 Apr; 174(4):895-7. PubMed ID: 26409069
    [No Abstract]   [Full Text] [Related]  

  • 15. Establishing melanocyte cultures in a serum-free system for transplantation in vitiligo patients.
    Czajkowski R; Placek W; Drewa T; Olszewska-Słonina D; Sir J; Kowaliszyn B; Weiss M
    Med Sci Monit; 2006 Feb; 12(2):CR63-9. PubMed ID: 16449949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Noncultured epidermal suspension transplantation for the treatment of stable vitiligo in children and adolescents.
    Sahni K; Parsad D; Kanwar AJ
    Clin Exp Dermatol; 2011 Aug; 36(6):607-12. PubMed ID: 21507039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Grafting of in vitro cultured melanocytes onto laser-ablated lesions in vitiligo.
    Kaufmann R; Greiner D; Kippenberger S; Bernd A
    Acta Derm Venereol; 1998 Mar; 78(2):136-8. PubMed ID: 9534893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suction blister epidermal grafts combined with CO2 laser superficial ablation as a good method for treating small-sized vitiligo.
    Ko WC; Chen YF
    Dermatol Surg; 2009 Apr; 35(4):601-6. PubMed ID: 19400882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Perspectives of surgical treatment of vitiligo].
    Trupar E; Brychta P
    Cas Lek Cesk; 2009; 148(3):129-31. PubMed ID: 19634273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of pulse energy variations on the dimensions of microscopic thermal treatment zones in nonablative fractional resurfacing.
    Bedi VP; Chan KF; Sink RK; Hantash BM; Herron GS; Rahman Z; Struck SK; Zachary CB
    Lasers Surg Med; 2007 Feb; 39(2):145-55. PubMed ID: 17096412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.